We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The government's response to recommendations made by the House of Commons Health and Social Care Committee's inquiry into Black maternal health.
Presented to Parliament by the Secretary of State for Health and Social…
This plan sets out how the government will reach its ambition of ending new HIV transmissions by 2030.
Ministerial foreword We have made huge progress on HIV in England. When I…
Introduction The public sector equality duty (PSED) that is set out in the…
Proposal to make a permanent order to prevent new patients aged under 18 from beginning to take puberty blockers for the purposes of gender incongruence and/or gender dysphoria, under the care of private prescribers.
Introduction Gender incongruence and/or gender dysphoria are conditions…
Introduction The general equality duty that is set out in the Equality Act…
Background On 20 August 2024, a targeted consultation was issued on…
The government's response to recommendations made by the House of Commons Women and Equalities Committee's inquiry into women’s reproductive health conditions.
Factsheet providing more information on the Commission on Human Medicines' independent report on the safety implications of proposed puberty blocker legislation.
Sets out the immediate actions government will be taking in the short term in response to the recommendations made in the independent Pregnancy Loss Review.
First published during the 2022 to 2024 Sunak Conservative government
Call for information to support a review of isotretinoin, a treatment for severe acne. This review is being undertaken by the Medicines and Healthcare products Regulatory Agency with advice from the Commission on Human Medic…
This call for evidence is seeking to collect views on women’s health. It will run for a period of 14 weeks and is open to everyone aged 16 or over.
First published during the 2019 to 2022 Johnson Conservative government
The plan sets out how we will achieve an 80% reduction in new HIV infections in England by 2025.
A 3-week public consultation on a proposal to make Hana 75 microgram film-coated tablets (Desogestrel) available from pharmacies.
A 3-week consultation on a proposal to make Lovima 75 microgram film-coated tablets (Desogestrel) available from pharmacies.
We are seeking views on proposals to revise the policy for chlamydia screening in England.
The National Chlamydia Screening Programme (NCSP) is changing to focus on reducing reproductive harm of untreated infection in young women.
The JCVI is seeking evidence to inform possible changes to the HPV immunisation programme. We would like evidence around one-dose schedules for the HPV vaccine.
The government's response to the Health and Social Care Committee's report on sexual health.
Government response to the House of Lords Report of session 2010 to 2012: No vaccine, no cure: HIV and AIDS.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).